Decision Curve Analysis for Evaluating Machine Learning Models for Next-Day Transfer Out of ICU
Margaret Pozo1,2, Abigail Pape3, Brian Locke4
1Department of Biomedical Engineering, The University of Utah, USA.
None:
Timely identification of intensive care unit (ICU) patients likely to exit the unit can support anticipatory workflows such as chart review, eligibility screening, and patient outreach prior to transfer. Most ICU discharge prediction studies report discrimination and calibration, but these metrics do not quantify the decision consequences of acting on predictions. Using adult ICU admissions from MIMIC-IV, we represented each ICU stay as a sequence of daily clinical summaries and trained logistic regression, random forest, and XGBoost models to predict next day ICU transfer. Models achieved ROC AUC of 0.80-0.84 with differing calibration. We evaluated decision utility using decision curve analysis (DCA), where positive predictions trigger proactive review. Across thresholds, model guided strategies outperformed review-all, review-none, and a simple clinical rule. To translate net benefit into implementable operations, we modeled a clinical trial recruitment workflow with an 8 hour daily time constraint, incorporating chart review and consent effort. At a feasible operating threshold (0.23), the model flagged ~23 charts/day and yielded ~1.23 enrollments/day under conservative eligibility and consent assumptions. These results demonstrate that DCA provides a transparent framework for determining when ICU transfer predictions are worth using and how thresholds should be selected to align with real world workflow constraints.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Receiver Operating Characteristic Plot
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
